.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Queensland Health
US Army
Johnson and Johnson
Cerilliant
Moodys
Dow
Julphar
UBS

Generated: July 28, 2017

DrugPatentWatch Database Preview

Metronidazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metronidazole and what is the scope of metronidazole freedom to operate?

Metronidazole
is the generic ingredient in nineteen branded drugs marketed by B Braun, Galderma Labs Lp, Tolmar, Intl Medication, Able, Teva Pharms, West-ward Pharms Int, Fougera Pharms, Medicis, Superpharm, Flamingo Pharms, Ivax Sub Teva Pharms, Mutual Pharm, Taro, Sandoz, Halsey, Par Pharm, Alembic Pharms Ltd, Allergan Sales Llc, Gd Searle Llc, Labs Af, Teva Pharms Usa, LNK, Savage Labs, Chartwell Molecules, Mylan Labs Ltd, Pliva, Watson Labs, Vivimed Labs, Valeant Pharms North, Watson Labs Inc, Appco Pharma Llc, G And W Labs, Taro Pharm, Pfizer, Baxter Hlthcare, Unichem Labs Ltd, Zydus Pharms Usa Inc, Strides Pharma, Abraxis Pharm, Ortho Mcneil Pharm, Allied Pharma Inc, Aurobindo Pharma Ltd, G And W Labs Inc, Orit Labs Llc, Claris, Abbott, and Hospira, and is included in seventy-four NDAs. There are eight patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Metronidazole has thirty-nine patent family members in nineteen countries.

There are eighteen drug master file entries for metronidazole. Eighty-one suppliers are listed for this compound.

Summary for Generic Name: metronidazole

Tradenames:19
Patents:8
Applicants:48
NDAs:74
Drug Master File Entries: see list18
Suppliers / Packagers: see list81
Bulk Api Vendors: see list110
Clinical Trials: see list289
Patent Applications: see list9,322
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metronidazole at DailyMed

Pharmacology for Ingredient: metronidazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
METRONIDAZOLE
metronidazole
TABLET;ORAL018517-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
METRONIDAZOLE
metronidazole
INJECTABLE;INJECTION018889-001Nov 18, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Claris
METRONIDAZOLE IN PLASTIC CONTAINER
metronidazole
INJECTABLE;INJECTION078084-001Mar 31, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer
FLAGYL I.V. RTU IN PLASTIC CONTAINER
metronidazole
INJECTABLE;INJECTION018353-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
METRONIDAZOLE
metronidazole
TABLET;ORAL018517-002May 5, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metronidazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
Galderma Labs Lp
METROGEL
metronidazole
GEL;TOPICAL019737-001Nov 22, 1988► Subscribe► Subscribe
Medicis
METROGEL-VAGINAL
metronidazole
GEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: metronidazole

Country Document Number Estimated Expiration
European Patent Office2238980► Subscribe
European Patent Office1467744► Subscribe
Russian Federation2004122696► Subscribe
Hong Kong1071514► Subscribe
Australia2012275292► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.



Supplementary Protection Certificates for Tradename: METRONIDAZOLE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Moodys
Cantor Fitzgerald
US Department of Justice
Julphar
Boehringer Ingelheim
Queensland Health
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot